Alkem Laboratories schedules investor meetings for September

Alkem Laboratories Limited has scheduled multiple investor meetings between September 12 and September 23, 2025, to engage with analysts and institutional investors. These meetings, held in accordance with SEBI Regulations, 2015, aim to provide updates and address queries regarding the company.

The schedule includes interactions with Nalanda Capital on September 12, ICICI Securities on September 17, and Equirus Securities (P) Limited on September 18. The meeting with Equirus Securities will be an in-person, one-on-one session held in Mumbai.

Further engagements include participation in the Kotak: Healthcare Forum 2025 on September 19 and the J.P. Morgan: Annual India Conference on September 23. Alkem Laboratories noted that the schedule is subject to change based on exigencies from either the investor or the company. The announcement was signed by Manish Narang, president – legal, company secretary & compliance officer.